<DOC>
	<DOCNO>NCT00130039</DOCNO>
	<brief_summary>This study recruit 480 acute stroke patient symptomatic intracranial stenosis ( M1 segment Middle cerebral artery ( MCA ) basilar artery ) . They randomly assign cilostazol group clopidogrel group . Every patient take 100mg aspirin day additionally . The primary outcome variable study Progression rate symptomatic intracranial stenosis magnetic resonance angiogram ( MRA ) .</brief_summary>
	<brief_title>Trial Cilostazol Symptomatic Intracranial Arterial Stenosis II</brief_title>
	<detailed_description>[ Goal ] To Reveal Effect Safety Cilostazol Compared Clopidogrel Prevention Progression Symptomatic Intracranial Arterial Stenosis . [ Trial Design ] Double-Blind , Active-Controlled , Randomized , Multicenter Trial [ Participants ] Acute ischemic stroke patient symptomatic intracranial arterial stenosis [ Methods ] - Double-Blind , Active-Controlled , Randomized , Multicenter Trial - Investigational product ( Double Dummy Method ) : Cilostazol 200mg ( 100mg twice per day ) versus clopidogrel 75mg - Concomitant medication : Aspirin 100 ( 75-150 ) mg per day - Medication Duration : 7 month [ Outcome Variables ] Primary Outcome Variable : - Progression rate symptomatic intracranial arterial stenosis Secondary outcome variable : - The occurrence new MRI ( magnetic resonance image ) lesion follow-up MRI - Stroke event - Overall cardiovascular event : stroke , acute coronary syndrome , vascular death - Ipsilateral ischemic stroke rate - Fatal major bleeding complication</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Cerebral infarction within 2 week onset TIA correspond acute ischemic brain lesion MRI within 2 week onset Age : 35 year age Patient significant focal stenosis M1 segment middle cerebral artery ( MCA ) basilar artery ( BA ) acute ischemic lesion magnetic resonance imaging ( MRI ) within vascular territory stenosed artery . Patients contraindication treatment antiplatelet therapy Patients potential cardiac embolic source ; prosthetic valve , atrial fibrillation , atrial flutter , leave atrial/atrial appendage thrombus , sick sinus syndrome , leave ventricular thrombus , dilate cardiomyopathy , akinetic hypokinetic leave ventricular segment , atrial myxoma , Infective endocarditis , mitral valve stenosis prolapse , mitral annuls calcification , leave atrial turbulence , nonbacterial endocarditis , congestive heart failure , recent myocardial infarction ( within 4 week ) Patients 50 % stenosis parent artery symptomatic stenosis Bleeding diathesis Chronic liver disease ( ALT &gt; 100 AST &gt; 100 ) chronic renal disease ( creatinine &gt; 3.0mg/dl ) Anemia ( hemoglobin &lt; 10mg/dl ) thrombocytopenia ( platelet count le 100,000/mm3 ) Nonatherosclerotic vasculopathy ; patient clinical characteristic suggest arterial dissection , moyamoya disease , Takayasu 's arteritis , radiation associate angiopathy , vasculitis . Severe stroke : NIH stroke scale : 16 Pregnant lactating patient Chronic user NSAIDs Thrombolytic therapy symptomatic stenosis Symptomatic stenosis schedule angioplasty Patients pacemaker contraindication MRI</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Infarction , Cerebral</keyword>
	<keyword>cilostazol</keyword>
	<keyword>stenosis</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>clopidogrel</keyword>
</DOC>